FierceBiotech Dec 9, 2025 ASH: Merck mulls future of polycythemia program while Takeda takes phase 3 victory lap
eLife Dec 9, 2025 Glycogen engineering improves the starvation resistance of mesenchymal stem cells and their therapeutic efficacy in pulmonary fibrosis
eLife Dec 9, 2025 Human neurocomputational mechanisms of guilt-driven and shame-driven altruistic behavior
FierceBiotech Dec 8, 2025 With weight loss windfall, Lilly looks to become ‘backbone’ of global innovation: exec
Endpoints News Dec 8, 2025 #ASH25: Will a biotech’s pivot away from obesity let it compete with Novartis in leukemia?
BioPharma Dive Dec 8, 2025 Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment